McMaster Textbook of Internal Medicine

McMaster Textbook of Internal Medicine
Interviews
Rheumatology
Is plasmapheresis effective in rheumatologic emergencies?

Is plasmapheresis effective in rheumatologic emergencies?

2018-12-20

Bhaskar Dasgupta

Recorded at the 4th McMaster International Review Course in Internal Medicine (MIRCIM).

Is plasmapheresis an effective treatment in rheumatologic emergencies?

Bhaskar Dasgupta, MD: It is a very efficacious way of treatment, but it is expensive. So you do not want to treat everyone with plasma exchange, and there are many patients who do not need plasma exchange. They can be treated with other conventional immunosuppression, cyclophosphamide, rituximab, and they do not need plasma exchange.

See also

Suspected secondary amyloidosis Secondary amyloidosis is a potentially fatal complication of chronic inflammatory diseases. When should it be suspected?
Frailty and the risk of fractures Is frailty associated with a risk of fractures? Is quantitative assessment of frailty possible?
Giant cell arteritis and other large vessel vasculitis A lecture by Dr Bhaskar Dasgupta, from Southend University Hospital, UK, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2017.
Colchicine in acute gout If colchicine in doses 1 g + 0.5 g is partly ineffective in a patient with acute gout, should it be continued at the same daily dose or is it better to switch to or add a nonsteroidal anti-inflammatory drug or a corticosteroid?
When to treat osteoporosis When should we consider treatment of osteoporosis? What is the best method to guide decision-making (Fracture Risk Assessment Tool, densitometry)?
Developments in the diagnosis and treatment of systemic vasculitis What is new in the diagnosis and treatment of systemic vasculitis?
Bisphosphonates in patients with moderate renal impairment Can bisphosphonates be used in patients with moderate renal impairment? What are the potential adverse effects of these drugs? Is denosumab a better choice in such patients?
2014 International Criteria for Behçet Disease What is new in the 2014 International Criteria for Behçet Disease?
Effectiveness of pharmacological treatment of osteoporosis in the elderly What is the effectiveness of pharmacological treatment of osteoporosis in elderly patients? Do bisphosphonates reduce the risk of fractures if started late in life, eg, in patients aged >80 years?
Treatment of frailty How to treat frailty?

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.